keyword
Keywords Indication for biopsy in nephr...

Indication for biopsy in nephrotic syndrome

https://read.qxmd.com/read/38650033/mutations-in-the-nup93-nup107-and-nup160-genes-cause-steroid-resistant-nephrotic-syndrome-in-chinese-children
#1
JOURNAL ARTICLE
Yanxinli Han, Hongyu Sha, Yuan Yang, Zhuowei Yu, Lanqi Zhou, Yi Wang, Fengjie Yang, Liru Qiu, Yu Zhang, Jianhua Zhou
BACKGROUND: The variants of nucleoporins are extremely rare in hereditary steroid-resistant nephrotic syndrome (SRNS). Most of the patients carrying such variants progress to end stage kidney disease (ESKD) in their childhood. More clinical and genetic data from these patients are needed to characterize their genotype-phenotype relationships and elucidate the role of nucleoporins in SRNS. METHODS: Four patients of SRNS carrying biallelic variants in the NUP93, NUP107 and NUP160 genes were presented...
April 22, 2024: Italian Journal of Pediatrics
https://read.qxmd.com/read/38591825/percutaneous-kidney-biopsies-in-children-a-24-year-review-in-a-tertiary-center-in-northern-portugal
#2
JOURNAL ARTICLE
Patrícia Sousa, Catarina Brás, Catarina Menezes, Ramon Vizcaino, Teresa Costa, Maria Sameiro Faria, Conceição Mota
INTRODUCTION: Percutaneous kidney biopsy (KB) is crucial to the diagnosis and management of several renal pathologies. National data on native KB in pediatric patients are scarce. We aimed to review the demographic and clinical characteristics and histopathological patterns in children who underwent native percutaneous KB over 24 years. METHODS: Retrospective observational study of patients undergoing native percutaneous KB in a pediatric nephrology unit between 1998 and 2021, comparing 3 periods: period 1 (1998-2005), period 2 (2006-2013), and period 3 (2014-2021)...
2024: Jornal Brasileiro de Nefrologia: ʹorgão Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
https://read.qxmd.com/read/38431824/determinants-of-non-diabetic-kidney-diseases-in-type-2-diabetic-patients-twenty-years-of-single-center-experience
#3
JOURNAL ARTICLE
Tamer Sakaci, Elbis Ahbap, Taner Basturk, Mustafa Ortaboz, Ayse Aysim Ozagari, Emrah Erkan Mazı, Kamile Gulcin Eken, Nuri Baris Hasbal, Abdulkadir Unsal
BACKGROUND: Diabetic nephropathy is one of the most common complications associated with diabetes. However, non-diabetic kidney disease has been reported in patients with type 2 diabetes at varying incidence rates. The objective of our study is to investigate the occurrence, clinicopathological characteristics, and inflammatory markers linked to diabetic and non-diabetic nephropathy (NDN) in patients with type 2 diabetes mellitus (DM). Additionally, we aimed to explore the possibility of identifying non-diabetic pathology using different biopsy indications...
March 3, 2024: Clinical Nephrology
https://read.qxmd.com/read/38393549/il-23-il-17-in-a-paradoxical-association-with-primary-membranous-nephropathy
#4
JOURNAL ARTICLE
Prabhjot Kaur, Arun Prabhahar, Deeksha Pal, Ritambhra Nada, Harbir Singh Kohli, Vinod Kumar, Raja Ramachandran
Primary membranous nephropathy (PMN), an autoimmune disease, is the most common cause of nephrotic syndrome in middle-aged non-diabetic adults. PMN pathophysiology includes Th1/Th2 paradigm. The IL-23/IL-17 pathway is implicated in autoimmune kidney disorders, but no study has examined its relationship with PMN. In several unrelated studies, PMN patients reported to have paradoxical IL-17 levels. This manuscript describes the best possible association of IL-23/IL-17 axis with PMN. Biopsy-proven PMN patients and age, gender-matched healthy controls were enrolled...
February 23, 2024: Inflammation
https://read.qxmd.com/read/38345590/spectrum-and-distribution-of-biopsy-proven-kidney-diseases-a-12-year-survey-of-a-single-center-in-iran
#5
JOURNAL ARTICLE
Fatemeh Nili, Elham Farahani, Mehran Moghimian, Issa Jahanzad, Farzaneh-Sadat Minoo, Samaneh Salarvand, Alireza Abdollahi, Seyed Ali Mirshahvalad
Data about the prevalence of biopsy-proven kidney diseases in Iran are rare, and none of the previous studies used electron microscopy for diagnosis. This study aimed to analyze the prevalence of biopsy-proven kidney diseases in Iran's primary referral center. To the best of our knowledge, this is the most extensive study carried out in Iran. Reports of kidney biopsy samples from patients referred to our center in 2007-2018 were reviewed for demographic data, clinical presentation, and final diagnosis. Statistical analyses were performed...
July 1, 2023: Saudi Journal of Kidney Diseases and Transplantation
https://read.qxmd.com/read/38337366/implementation-of-kidney-biopsy-in-one-of-the-poorest-countries-in-the-world-experience-from-zinder-hospital-niger
#6
JOURNAL ARTICLE
Hassane Moussa Diongolé, Zeinabou Maiga Moussa Tondi, Abdoulazize Garba, Kabirou Ganiou, Laouali Chaibou, Djibrilla Bonkano, Illiassou Aboubacar, Abdoul Aziz Seribah, Abdoul Madjid Abdoulaye Idrissa, Akinfenwa Atanda, Lionel Rostaing
Kidney biopsy (KB) has become essential in the nephrologist's approach to kidney diseases, both for diagnosis, treatment, and prognosis. Our objective is to describe the preliminary results of KBs in Niger, one of the poorest countries in the world. This is a descriptive cross-sectional study that took place over 36 months in the nephrology/dialysis department of the Zinder National Hospital. Biopsy results were obtained in less than 5 working days. Patients were responsible for covering the cost of the kidney biopsy...
January 24, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38336610/nephrotic-syndrome-with-acute-kidney-injury-due-to-combination-therapy-of-immune-checkpoint-inhibitors-a-case-report-and-review-of-the-literature
#7
REVIEW
Ryosuke Saiki, Kan Katayama, Haruko Saiki, Ayumi Fukumori, Kayo Tsujimoto, Masahiro Yamawaki, Fumika Tanaka, Daisuke Takahashi, Keiko Oda, Yasuo Suzuki, Tomohiro Murata, Kaoru Dohi
BACKGROUND: Recent studies have focused on immune checkpoint inhibitors. Renal complications associated with the use of immune checkpoint inhibitors are uncommon compared with other immune-related adverse events. Acute interstitial nephritis accounts for most of these renal complications, with nephrotic syndrome quite rare. We herein report a case of nephrotic syndrome associated with immune checkpoint inhibitors that was more severe than that in previous cases. By comparing this case with previous reports, the possible reasons for the particular severity of this case are discussed...
February 9, 2024: BMC Nephrology
https://read.qxmd.com/read/38230299/bleeding-complications-after-percutaneous-kidney-biopsies-nationwide-experience-from-brunei-darussalam
#8
JOURNAL ARTICLE
Chiao Yuen Lim, Sai Laung Khay
BACKGROUND: Kidney biopsy serves as a valuable method for both diagnosing and monitoring kidney conditions. Various studies have identified several risk factors associated with bleeding complications following the procedure, but these findings have shown inconsistency and variation. AIM: To investigate the risk of bleeding complications following percutaneous kidney biopsy in Brunei Darussalam. We sought to explore the relevant clinical and pathological risk factors associated with these complications while also considering the findings within the broader international literature context...
December 25, 2023: World Journal of Nephrology
https://read.qxmd.com/read/38123711/kidney-biopsy-findings-in-children-with-diabetes-mellitus
#9
JOURNAL ARTICLE
Lasanthi Weerasooriya, Alexander J Howie, Matthew P Wakeman, Susan Cavanagh, David V Milford
BACKGROUND: Diabetic nephropathy may begin in childhood, but clinical kidney disease ascribable to this is uncommon in children with type 1 (insulin dependent) diabetes mellitus. METHODS: We reviewed our experience of kidney biopsies in children with type 1 diabetes mellitus. RESULTS: Between 1995 and 2022, there were biopsies in 17 children, with various clinical indications for kidney biopsy, making this the largest series of biopsies in diabetic children with clinical kidney abnormalities...
December 21, 2023: Pediatric Nephrology
https://read.qxmd.com/read/38114708/evaluation-of-glomerular-sirtuin-1-and-claudin-1-in-the-pathophysiology-of-nondiabetic-focal-segmental-glomerulosclerosis
#10
JOURNAL ARTICLE
Guilherme Lopes-Gonçalves, Juliana Martins Costa-Pessoa, Ruan Pimenta, Ana Flavia Tostes, Eloisa Martins da Silva, Felipe Lourenço Ledesma, Denise Maria Avancini Costa Malheiros, Roberto Zatz, Karina Thieme, Niels Olsen Saraiva Câmara, Maria Oliveira-Souza
Focal segmental glomerulosclerosis (FSGS) is the leading cause of nephrotic syndrome, which is characterized by podocyte injury. Given that the pathophysiology of nondiabetic glomerulosclerosis is poorly understood and targeted therapies to prevent glomerular disease are lacking, we decided to investigate the tight junction protein claudin-1 and the histone deacetylase sirtuin-1 (SIRT1), which are known to be involved in podocyte injury. For this purpose, we first examined SIRT1, claudin-1 and podocin expression in kidney biopsies from patients diagnosed with nondiabetic FSGS and found that upregulation of glomerular claudin-1 accompanies a significant reduction in glomerular SIRT1 and podocin levels...
December 19, 2023: Scientific Reports
https://read.qxmd.com/read/38106713/large-b-cell-lymphoma-associated-membranous-nephropathy-with-positive-pla2r-on-kidney-biopsy
#11
Mina Al-Khazraji, Inam A Al-Mufti, Yamama Al-Khazraji
Large B-cell lymphoma associated with membranous nephropathy (MN) is a rare and complex medical condition that involves the simultaneous presence of two distinct diseases: a malignant lymphoma and a kidney disorder called membranous nephropathy. In this case, there is an additional element of interest, which is the presence of positive Phospholipase A2 Receptor (PLA2R) in the kidney. The case involves a 53-year-old Caucasian male with a three-week history of lower leg edema and a past medical history of recurrent upper respiratory infections...
November 2023: Curēus
https://read.qxmd.com/read/38011679/-epidemiology-of-glomerular-disease-report-from-a-third-level-center
#12
JOURNAL ARTICLE
Alejandra Itzel Martínez-Abadía, José Óscar Juárez-Sánchez
BACKGROUND: Renal biopsy has become one of the pillars of nephrology practice, being a very important tool in the diagnostic approach of any nephrology center, since it contributes to the identification and adequate management of glomerular diseases, which represent the third cause of chronic kidney disease in the world. In Mexico there are few reports on the epidemiology of glomerular diseases; therefore, it is important to carry out this type of study. OBJECTIVE: To identify which are the main glomerulopathies reported in our center, Determine the most prevalent glomerular syndrome according to the reported glomerulopathy, and identify the main complications after percutaneous renal biopsy...
September 18, 2023: Revista Médica del Instituto Mexicano del Seguro Social
https://read.qxmd.com/read/37942512/patients-with-primary-focal-segmental-glomerulosclerosis-with-detectable-urinary-cd80-are-more-similar-to-patients-with-minimal-change-disease-in-clinicopathological-features
#13
JOURNAL ARTICLE
Xiaojie Gong, Jing Huang, Yimiao Zhang, Fang Wang, Xin Wang, Liqiang Meng, Xuyang Cheng, Gang Liu, Zhao Cui, Minghui Zhao
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is an important cause of refractory nephrotic syndrome (NS) in children and adults. Urinary CD80 is elevated in some patients with primary FSGS, however, its clinical value is not fully clarified. This study aims to evaluate the clinical and pathological significance of urinary CD80 in patients with primary FSGS. METHODS: Sixty-one adult patients with biopsy-proven primary FSGS, with standard treatment and long-term follow up, were enrolled retrospectively...
2023: Renal Failure
https://read.qxmd.com/read/37924431/practice-patterns-of-rituximab-for-primary-membranous-nephropathy-2021-in-japan-a-web-based-survey-of-board-certified-nephrologists
#14
JOURNAL ARTICLE
Yoshitaka Miyaoka, Noriaki Kurita, Tadashi Sofue, Hiroki Nishiwaki, Masahiro Koizumi, Sayaka Shimizu, Sho Sasaki, Takuji Ishimoto, Takehiko Wada
BACKGROUND: Although rituximab (RTX) is recommended by kidney disease improving global outcomes as one of the standard therapies for primary membranous nephropathy (pMN), given the constraint of insurance coverage, it is not clear how the drug is used in Japan. METHODS: This cross-sectional study was conducted via a web-based survey between November and December 2021. The participants were certified nephrologists and recruited through convenience sampling. Experience with RTX for pMN was compared to experience with RTX for minimal change nephrotic syndrome (MCNS)...
November 4, 2023: Clinical and Experimental Nephrology
https://read.qxmd.com/read/37906746/-frequency-of-glomerular-diseases-in-an-analysis-of-550-kidney-biopsies
#15
JOURNAL ARTICLE
Ricardo Valjalo, María T Mallea
BACKGROUND: The frequency of glomerular diseases is dynamic and varies according to geographic area. AIM: To evaluate the frequency of primary and secondary glomerulopathies, their demographic profile and main clinical characteristics. MATERIAL AND METHODS: Renal biopsies from native kidneys performed between 1999 and 2020 were retrospectively reviewed. Demographic characteristics, clinical presentation, most relevant laboratory tests, frequency of primary and secondary glomerulopathies were analyzed...
February 2023: Revista Médica de Chile
https://read.qxmd.com/read/37881740/minimal-change-nephrotic-syndrome-in-a-child-with-systemic-lupus-erythematosus
#16
Pankaj V Deshpande
Renal involvement in systemic lupus erythematosus (SLE) is well known. We present a 16-year-old boy, who was in remission on treatment for SLE for the past three years and now presented with nephrotic syndrome. The kidney biopsy was normal with the immunofluorescence revealing no deposits. He went into remission by day 9 of treatment and completed the course of treatment with prednisolone alone with no relapses. The clinical picture along with the histology and autoimmune markers for SLE indicate that he developed minimal change nephrotic syndrome that was responsive to prednisolone...
2023: Indian Journal of Nephrology
https://read.qxmd.com/read/37866673/a-case-report-and-literature-study-on-alport-syndrome-featuring-nephrotic-syndrome-as-its-primary-manifestation
#17
Zhuo Deng, Qi Zhou, Tai-Guang Zhou
BACKGROUND: Historically, due to the lack of distinct clinical symptoms, Alport syndrome, a hereditary kidney disease prevalent in children and a leading cause of kidney failure, has often been misdiagnosed as other kidney conditions. CASE DESCRIPTION: This article presents a comprehensive review and analysis of clinical data concerning a child diagnosed with Alport syndrome, where nephrotic syndrome served as the primary manifestation. The male child in this case exhibited symptoms starting at the age of 6, initially diagnosed as nephrotic syndrome...
October 20, 2023: Transplant Immunology
https://read.qxmd.com/read/37850851/clinical-significance-of-massive-proteinuria-in-primary-iga-nephropathy-with-and-without-nephrotic-syndrome-a-single-center-cohort-study
#18
JOURNAL ARTICLE
Ya Hu, Ziyuan Huang, Qianqian Cao, Bo Chen, Shungang Xu, Wenxian Qiu, Xiaohan You, Ji Zhang, Chaosheng Chen
BACKGROUND: Both primary IgA nephropathy (IgAN) with and without nephrotic syndrome (NS) can present massive proteinuria (24-h urinary protein ≥3.5 g/d). The clinical significance of massive proteinuria may be different in the two entities and needs further research. METHODS: Data of 1870 patients with biopsy-proven IgAN in our hospital from January 2011 to December 2022 was retrospectively reviewed. A total of 242 IgAN patients with massive proteinuria were enrolled...
2023: Renal Failure
https://read.qxmd.com/read/37835066/renal-biopsy-for-diagnosis-in-kidney-disease-indication-technique-and-safety
#19
REVIEW
Peter Schnuelle
Renal biopsies are the gold standard for diagnosis, staging, and prognosis of underlying parenchymal kidney disease. This article provides an overview of the current indications and highlights ways to reduce bleeding complications in order to achieve optimal diagnostic yield with minimal risk to the patient. Novel indications have emerged from the increasing use of new molecularly targeted oncologic therapies in recent years, which often induce immune-mediated renal disease. On the other hand, the detection of specific antibodies against target antigens on podocytes in the sera of patients with new-onset nephrotic syndrome has now relativized the indication for biopsy in membranous nephropathy...
October 9, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37818552/the-importance-of-sphingomyelin-phosphodiesterase-acid-like-3b-smpdl-3b-levels-in-kidney-biopsy-specimens-of-children-with-nephrotic-syndrome
#20
JOURNAL ARTICLE
Muhammet Kaya, İlknur Girişgen, Nagihan Yalçın, Tülay Becerir, Hande Şenol, Gülsün Gülten, Selcuk Yüksel
OBJECTIVE: It remains unclear whether the low amount of SMPDL-3b required for rituximab binding is the cause of treatment resistance in patients with treatment-resistant nephrotic syndrome with advanced podocyte injury. Given the limited number of studies on the relationship between rituximab and SMPDL-3b, this study was conducted to assess whether SMPDL-3b levels in pretreatment renal biopsy specimens can be used to predict the clinical effectiveness of immunosuppressive drugs, especially rituximab, in children with nephrotic syndrome...
October 11, 2023: Fetal and Pediatric Pathology
keyword
keyword
113431
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.